254 related articles for article (PubMed ID: 27832086)
21. Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
Acar A; Guzel S; Sarifakioglu B; Guzel EC; Guzelant AY; Karadag C; Kiziler L
Clin Rheumatol; 2016 Nov; 35(11):2685-2692. PubMed ID: 27094943
[TBL] [Abstract][Full Text] [Related]
22. Musculoskeletal ultrasound for predicting remission in patients with rheumatoid arthritis: results from a 1-year prospective study.
Sapundzhieva T; Karalilova R; Batalov A
Rheumatol Int; 2018 Oct; 38(10):1891-1899. PubMed ID: 30121699
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
24. Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.
García-Arias M; Pascual-Salcedo D; Ramiro S; Ueberschlag ME; Jermann TM; Cara C; Martín-Mola E; Balsa A
Mol Diagn Ther; 2013 Feb; 17(1):49-56. PubMed ID: 23329363
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study.
Hammer HB; Kvien TK; Terslev L
Arthritis Res Ther; 2017 Oct; 19(1):221. PubMed ID: 28978340
[TBL] [Abstract][Full Text] [Related]
26. Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
Sakellariou G; Lombardi G; Vitolo B; Gomarasca M; Faraldi M; Caporali R; Banfi G; Montecucco C
Clin Exp Rheumatol; 2019; 37(3):429-436. PubMed ID: 30299248
[TBL] [Abstract][Full Text] [Related]
27. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.
Torgutalp M; Yayla ME; Eroglu DS; Dincer ABK; Yurteri EU; Okatan IE; Sezer S; Guloksuz EGA; Us E; Turgay TM; Kinikli G; Ates A
Mediterr J Rheumatol; 2021 Mar; 32(1):56-65. PubMed ID: 34386702
[TBL] [Abstract][Full Text] [Related]
28. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.
da Silva Chakr RM; Brenol JC; Behar M; Mendonça JA; Kohem CL; Monticielo OA; Brenol CV; Xavier RM
PLoS One; 2015; 10(3):e0118620. PubMed ID: 25738587
[TBL] [Abstract][Full Text] [Related]
29. Deep clinical remission: an optimised target in the management of rheumatoid arthritis? Experience from an ultrasonography study.
Geng Y; Han J; Deng X; Zhang Z
Clin Exp Rheumatol; 2016; 34(4):581-6. PubMed ID: 27050636
[TBL] [Abstract][Full Text] [Related]
30. Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.
de Moel EC; Rech J; Mahler M; Roth J; Vogl T; Schouffoer A; Goekoop RJ; Huizinga TWJ; Allaart CF; Toes REM; Schett G; van der Woude D
Arthritis Res Ther; 2019 Dec; 21(1):268. PubMed ID: 31805992
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound joint inflammation in rheumatoid arthritis in clinical remission: how many and which joints should be assessed?
Naredo E; Valor L; De la Torre I; Martínez-Barrio J; Hinojosa M; Aramburu F; Ovalles-Bonilla JG; Hernández D; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L
Arthritis Care Res (Hoboken); 2013 Apr; 65(4):512-7. PubMed ID: 23044729
[TBL] [Abstract][Full Text] [Related]
32. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis.
Ramírez J; Inciarte-Mundo J; Cuervo A; Celis R; Ruiz-Esquide V; Castellanos-Moreira R; Ponce A; Gómez-Puerta JA; Sanmartí R; Cañete JD
Clin Rheumatol; 2021 Jul; 40(7):2665-2672. PubMed ID: 33506371
[TBL] [Abstract][Full Text] [Related]
33. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
34. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
Chandrashekara S; Priyanka BU
Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Remission or Combined Remission and Low Disease Activity in Rheumatoid Arthritis Patients in Taiwan: A Prospective Cohort Study.
Tsai PH; Fang YF; Chen YF; Chen CC; Chiang WY; Chang CT; Huang YJ; Liou LB
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731049
[No Abstract] [Full Text] [Related]
36. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
37. Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.
Nordal HH; Fagerhol MK; Halse AK; Hammer HB
Scand J Clin Lab Invest; 2018; 78(1-2):102-108. PubMed ID: 29278951
[TBL] [Abstract][Full Text] [Related]
38. Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate.
Nielsen UB; Bruhn LV; Ellingsen T; Stengaard-Pedersen K; Hornung N
Scand J Clin Lab Invest; 2018; 78(1-2):62-67. PubMed ID: 29228799
[TBL] [Abstract][Full Text] [Related]
39. The relation between composite ultrasound measures and the DAS28 score, its components and acute phase markers in adult RA.
Hameed B; Pilcher J; Heron C; Kiely PD
Rheumatology (Oxford); 2008 Apr; 47(4):476-80. PubMed ID: 18281367
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
Smolen JS; Aletaha D
Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
